Short chain fatty acids stimulate insulin secretion and reduce apoptosis in mouse and human islets in vitro: Role of free fatty acid receptor 2.


Journal

Diabetes, obesity & metabolism
ISSN: 1463-1326
Titre abrégé: Diabetes Obes Metab
Pays: England
ID NLM: 100883645

Informations de publication

Date de publication:
02 2019
Historique:
received: 19 06 2018
revised: 29 08 2018
accepted: 05 09 2018
pubmed: 12 9 2018
medline: 10 9 2019
entrez: 12 9 2018
Statut: ppublish

Résumé

To evaluate the role of free fatty acid receptor 2 (FFAR2)/G-protein coupled receptor 43 in mediating the effects of the short chain fatty acids (SCFAs) sodium acetate (SA) and sodium propionate (SP) on islet function in vitro, and to identify the intracellular signalling pathways used in SCFA-induced potentiation of glucose-induced insulin secretion. Islets of Langerhans were isolated from wild-type and FFAR2 Deletion of FFAR2 did not affect islet morphology or insulin content. SA and SP reversibly potentiated insulin secretion from mouse islets in a FFAR2-dependent manner. SCFA-induced potentiation of insulin secretion was coupled to Gq activation of phospholipase C and protein kinase C, with no evidence of Gi-mediated signalling. SA and SP protected human and mouse islets from apoptosis, and these pro-survival properties were dependent on islet expression of FFAR2. Our results indicate that FFAR2 directly mediates both the stimulatory effects of SA and SP on insulin secretion and their protection against islet apoptosis. We have also shown that SCFA coupling in islets occurs via Gq-coupled intracellular signalling.

Identifiants

pubmed: 30203438
doi: 10.1111/dom.13529
doi:

Substances chimiques

FFA2R protein, human 0
Fatty Acids, Nonesterified 0
Fatty Acids, Volatile 0
Ffar2 protein, mouse 0
Insulin 0
Propionates 0
Receptors, Cell Surface 0
Receptors, G-Protein-Coupled 0
Sodium Acetate 4550K0SC9B
sodium propionate DK6Y9P42IN

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

330-339

Subventions

Organisme : Department of Health
ID : EME/15/185/16
Pays : United Kingdom

Informations de copyright

© 2018 John Wiley & Sons Ltd.

Auteurs

Attilio Pingitore (A)

Department of Diabetes, Faculty of Life Sciences and Medicine, King's College London, London, UK.

Noemi Gonzalez-Abuin (N)

Division of Human Nutrition, Faculty of Medicine, Imperial College London, London, UK.

Inmaculada Ruz-Maldonado (I)

Department of Diabetes, Faculty of Life Sciences and Medicine, King's College London, London, UK.

Guo C Huang (GC)

Department of Diabetes, Faculty of Life Sciences and Medicine, King's College London, London, UK.

Gary Frost (G)

Division of Human Nutrition, Faculty of Medicine, Imperial College London, London, UK.

Shanta J Persaud (SJ)

Department of Diabetes, Faculty of Life Sciences and Medicine, King's College London, London, UK.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH